Sixty Degree Capital invests in the evolving areas of biopharmaceuticals, healthcare platforms and technology. Engaging with companies throughout North America, they aim to remove the barriers between us and our potential in order to make present visions a reality. Holistically, Sixty Degree Capital invests in companies creating meaningful change in their industries, across sectors (software, digital infrastructure, healthcare, biotech) and across stages (as early as Series A, as late as pre-IPO).